The diagnosis and management of gastric cancer: expert discussion and recommendations from the 12th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2010
E Van Cutsem, M Dicato, R Geva, N Arber, Y Bang, A Benson, A Cervantes, E Diaz-Rubio, M Ducreux, R Glynne-Jones, A Grothey, D Haller, K Haustermans, D Kerr, B Nordlinger, J Marshall, B D Minsky, Y K Kang, R Labianca, F Lordick, A Ohtsu, N Pavlidis, A Roth, P Rougier, H J Schmoll, A Sobrero, J Tabernero, C Van de Velde, J Zalcberg, E Van Cutsem, M Dicato, R Geva, N Arber, Y Bang, A Benson, A Cervantes, E Diaz-Rubio, M Ducreux, R Glynne-Jones, A Grothey, D Haller, K Haustermans, D Kerr, B Nordlinger, J Marshall, B D Minsky, Y K Kang, R Labianca, F Lordick, A Ohtsu, N Pavlidis, A Roth, P Rougier, H J Schmoll, A Sobrero, J Tabernero, C Van de Velde, J Zalcberg
Abstract
Well-recognized experts in the field of gastric cancer discussed during the 12th European Society Medical Oncology (ESMO)/World Congress Gastrointestinal Cancer (WCGIC) in Barcelona many important and controversial topics on the diagnosis and management of patients with gastric cancer. This article summarizes the recommendations and expert opinion on gastric cancer. It discusses and reflects on the regional differences in the incidence and care of gastric cancer, the definition of gastro-esophageal junction and its implication for treatment strategies and presents the latest recommendations in the staging and treatment of primary and metastatic gastric cancer. Recognition is given to the need for larger and well-designed clinical trials to answer many open questions.
Source: PubMed